Gabapentinoids and the risk of severe exacerbations in patients with chronic obstructive pulmonary disease - Milan 2023

Risks of hospitalisation and mortality from chronic lung diseases

Chair(s): Om Prakash Kurmi, Ramesh Chokhani

Session type: Oral presentation

Gabapentinoids and the risk of severe exacerbations in patients with chronic obstructive pulmonary disease

Alvi Rahman

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Colostrum microbiome and childhood allergy

Caroline Lodge

Replay

Poster

Abstract

Slides

Profiles of pregnancy and early-life urban and lifestyle exposures and respiratory health in children

Alicia Guillien

Replay

Poster

Abstract

Slides

Risk of asthma in offspring of asthmatic fathers versus mothers: A population-based study of 21,000 individuals in Denmark

Morten Dahl

Replay

Poster

Abstract

Slides

Gabapentinoids and the risk of severe exacerbations in patients with chronic obstructive pulmonary disease

Alvi Rahman

Replay

Abstract

Slides

Long-term outcomes between adults with and without breathlessness: a UK cohort study

Urvee Karsanji

Replay

Poster

Abstract

Slides

Treatment intensity level as a proxy for severity of COPD: A nationwide cohort study

Marie Dam Lauridsen

Replay

Poster

Abstract

Slides

Respiratory symptom clusters and cause-specific mortality in a representative adult population

Daniil Lisik

Replay

Poster

Abstract

Slides

Long-term air pollution exposure and risk of SARS-CoV-2 infection: A UK-wide cohort study

Hajar Hajmohammadi

Replay

Abstract

Slides

Lifetime body mass index trajectories and lung function and chronic obstructive pulmonary disease in the Tasmanian longitudinal health study (TAHS)

Gulshan Ali

Replay

Poster

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}